ifosfamide has been researched along with Atherosclerotic Parkinsonism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laurie, C | 1 |
| Reynolds, A | 1 |
| Coskun, O | 1 |
| Bowman, E | 1 |
| Gendelman, HE | 1 |
| Mosley, RL | 1 |
1 other study available for ifosfamide and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adoptive Transfer; Animals; Antineoplastic Combined Ch | 2007 |